Oral Solid Dose CDMOs

UPM Pharmaceuticals

United States

UPM Pharmaceuticals is a U.S.-based CDMO specializing in late-stage commercial manufacturing of semi-solid and oral solid dose products. Operating from a 475,000 sq ft cGMP FDA-registered facility in Bristol, Tennessee, UPM is a family-owned company with 30+ years of experience. They handle DEA-controlled substances and provide services from technology transfer and scale-up through commercial manufacturing. Capabilities include formulation development, analytical development, coated tablet manufacturing, pharmaceutical serialization, aggregation, and full packaging and warehousing.

OneSource Specialty Pharma Limited

India

OneSource Specialty Pharma Limited (formerly Stelis Biopharma Limited) is India's first specialty pharma pure-play CDMO, offering multimodal end-to-end capabilities across drug-device combinations, complex sterile injectables, biologics, and soft gelatin capsules. The company operates five state-of-the-art facilities in Bengaluru with 35 approved ANDAs and 19 commercialized drug products in the US market.

Hiral Labs Ltd

India

Hiral Labs Ltd is an Indian pharmaceutical contract manufacturer established in 2000, based near Roorkee, Uttarakhand. The company operates two WHO-GMP and ISO-certified manufacturing sites producing liquid injections, tablets, capsules, ointments, syrups, eye/ear drops, and oncology injections (including lyophilized). Hiral Labs manufactures over 350 formulations on a contractual basis for more than 300 companies across approximately 4,000 brands.

Prime Health Ltd. is a contract manufacturer for natural health products, nutritional supplements, and pharmaceutical products. Based in Maple Ridge, British Columbia, Canada (not UK as listed), they have a modern facility with advanced equipment. Job postings mention production workers for tablet coating, quality control technicians, R&D technicians, encapsulation roles, and formulation technicians. FDA-registered with FEI 3021784212 with 1 FDA inspection (VAI in 2022). Also listed on PharmaSource as a contract manufacturer and appearing at CPHI Frankfurt. The UK-based Prime Health referenced by Apposite Capital appears to be a different entity (www.prime-health.co.uk).

Polpharma / Polpharma API

Kazakhstan

Polpharma is the leader of the Polish pharmaceutical market and one of the leading drug manufacturers in Central and Eastern Europe, with origins dating to 1935. Produces 400 million packages annually across 5 manufacturing plants and 3 R&D centers. The group includes Polpharma API (CDMO/API manufacturing), Polpharma Biologics (state-of-the-art biologic manufacturing including biosimilars and innovative molecules), and Farmaprojects (B2B hub). Has received grants for RNA-based medicines development under the STEP initiative. FDA registered for API manufacture.

Onko Ilac Sanayi ve Ticaret A.S. is a Turkish pharmaceutical company offering contract manufacturing and out-licensing services. The company manufactures finished dosage form pharmaceutical products including oncology drugs (fingolimod, pemetrexed, temozolomide, abiraterone) and other therapeutic areas, exhibiting regularly at CPHI events.

Helba İlaç İç ve Dış San. Tic. A.Ş.

Turkey

Helba Pharma is a Turkish pharmaceutical manufacturer established in 2008, with roots in Welfar Pharma founded in Azerbaijan in 1995. The company produces solid and semi-solid form medicines at its GMP-certified production facility with 50 million box manufacturing capacity, and actively exports to CIS countries, Balkans, and Middle Eastern markets.

Meenaxy Pharma Pvt Ltd.

India

Meenaxy Pharma Pvt Ltd is an Indian pharmaceutical company with over 20 years of experience specializing in the manufacture of pharmaceutical pellets and capsules. WHO GMP and ISO 9001:2015 certified, the company is a pioneer in novel drug delivery systems, producing neutral pellets (non-pareil seeds, sugar spheres USP, tartaric acid pellets, di-calcium phosphate pellets, MCC pellets), active drug coated pellets (doxycycline, omeprazole, curcumin, orlistat, indomethacin ER, itraconazole, dexlansoprazole, ketoprofen ER, mebeverine HCl SR), enteric coated pellets, and blended pellets (iron folic, mineral & vitamin). They serve clients including GSK, Aurobindo, and Dr. Reddy's, and export to 20+ countries. The company operates two manufacturing facilities with capsule filling capabilities and contract manufacturing services.

SIDEFARMA

Portugal

SIDEFARMA is a Portuguese CMO with over 45 years of experience, specialized in the manufacture of small and medium-size batches of solid dosage forms (coated tablets, tablets, capsules), semi-solids (creams, gels, ointments), and liquid pharmaceuticals. The company provides contract manufacturing, contract packaging, and contract development services following European quality standards, while also commercializing its own branded pharmaceutical products.

Macleods Pharmaceuticals Ltd

India

Macleods Pharmaceuticals Ltd is one of India's top 10 pharmaceutical companies, operating as a CDMO for developing, manufacturing, and globally distributing pharmaceutical products. They produce diverse dosage forms including solid orals, liquid orals, topical formulations, injectables, metered dose inhalers, and dry powder inhalers across therapeutic areas including anti-TB, antimalarials, antiretrovirals, antidiabetics, antihypertensives, and antiasthmatics. They have 152 FDA-approved products, WHO prequalified medicines, and manufacturing facilities compliant with UK MHRA, US FDA, TGA, and WHO guidelines. They operate in 100+ countries.

Akums Drugs & Pharmaceuticals Ltd

India

Akums Drugs & Pharmaceuticals Ltd. is India's largest CDMO with 30% domestic market share, operating 15+ state-of-the-art manufacturing facilities with over 4,100 commercialized formulations across 60+ dosage forms. The company serves 1,500+ pharmaceutical companies and provides end-to-end services including API manufacturing (737 MT annual capacity across 3 facilities), formulation development, clinical trial materials, and commercial-scale production of tablets, capsules, injectables, soft gels, syrups, topicals, and nutraceuticals.

Tirupati Group is one of India's largest contract development and manufacturing organizations (CDMOs), providing end-to-end solutions across pharmaceuticals, nutraceuticals, Ayurveda, and sports nutrition. Founded in 2005, the company operates state-of-the-art manufacturing facilities in Paonta Sahib (Himachal Pradesh) and Noida (Uttar Pradesh), serving 350+ clients including Abbott, Pfizer, Dr. Reddy's, and Sun Pharma.

Lachifarma is an Italian CMO/CDMO based in Zollino (Lecce), Italy, offering research, technological development, and pharmaceutical contract manufacturing services. Listed as an EU GMP CMO, it appears in European CDMO landscape analyses alongside companies like Fine Foods, Doppel, and Biofarma. Lachifarma has been involved in vaccine-related contract manufacturing and offers pharmaceutical dose manufacturing services.

Davipharm

Vietnam

Davipharm (Dat Vi Phu Pharmaceutical JSC) is a Vietnamese pharmaceutical manufacturer and member of the Adamed group, holding EU GMP certification. The company manufactures over 300 generic drug products at its facility in Binh Duong, Vietnam, and offers CMO/CDMO services including high-potency drug manufacturing. Davipharm recently expanded its capacity and capabilities in high-potency manufacturing.

Biomatrix Healthcare Pvt. Ltd.

India

BioMatrix Healthcare Pvt. Ltd. is an Indian pharmaceutical company established in 2007, headquartered in Ahmedabad, specializing in 100% export of pharmaceutical products to 40+ countries. Their manufacturing facility is WHO-GMP, EU-GMP certified and compliant with US-FDA, UK-MHRA, and ANVISA standards, with Health Canada site approval. Capacity: 5 billion tablets, 1 billion capsules, 24 million liquids, and 18 million dry syrups per annum. 1,000+ product registrations. Expanding with a new API manufacturing facility in Vadodara.

Porton Pharma Solutions

China

Porton Pharma Solutions is a global CDMO headquartered in China with over 4,300 employees and operations in the US, Europe (Slovenia), and China. They offer end-to-end services across small molecules, tides (peptides/oligonucleotides), biologics and conjugates (ADCs), and advanced therapy medicinal products. Technical solutions include crystallization, bio catalysis, metal catalysis, flow chemistry, preparative chromatography, milling, and chemical engineering. FDA-registered with 4 FEI numbers for API manufacture, they have 3 FDA inspections with clean outcomes (1 NAI, 2 VAI).

Lyomark Pharma GmbH

Germany

Lyomark Pharma GmbH is a German CDMO specializing in sterile medicinal products. They organize contract manufacturing based on dossiers they compile and maintain, and offer regulatory services. Through their subsidiary Lyocontract, they operate a state-of-the-art pharmaceutical manufacturing site. They have 39 FDA-approved products across injectable, oral solid, and liquid dosage forms. The company focuses on niche indications for the hospital market with global distribution.

Novugen Pharma

Malaysia

Novugen Pharma is a Malaysian pharmaceutical company and CDMO subsidiary of UAE-based SciTech International, providing vertically integrated API and finished dosage form development and manufacturing. The company has USFDA-approved facilities including a dedicated oncology manufacturing plant. Novugen achieved zero Form 483 citations from USFDA and holds Halal pharmaceutical certification.

Life Pharma FZE

United Arab Emirates

Life Pharma FZE (LIFEPharma) is a UAE-based pharmaceutical manufacturer and the only USFDA-approved pharmaceutical company in the United Arab Emirates. Part of VPS Healthcare, the company manufactures a wide range of generic finished dosage forms including tablets, capsules, and liquid oral preparations at its facility in Jebel Ali, Dubai. LIFEPharma is building a new oncology manufacturing facility in Abu Dhabi.

XL LABORATORIES PVT LTD

India

XL Laboratories Pvt Ltd is an EU GMP, PIC/s, TGA, and WHO GMP approved pharmaceutical formulations and nutraceuticals research and manufacturing company established in 2001. It holds Star Export House status from the Indian Ministry of Commerce for outstanding international market performance, with presence in 40+ countries.

China Resources Zizhu Pharmaceutical Co., Ltd. (CRZP), founded in 1969, is a high-tech pharmaceutical enterprise and subsidiary of China Resources Pharmaceutical. The company manufactures APIs and finished dosage forms including tablets, oral liquids, and topicals, with FDA registration and 5 FDA inspections on record, and 2 FDA-approved products.

Aarti Pharmalabs Limited

India

Aarti Pharmalabs Limited is a leading Indian small-molecule CDMO specializing in API and drug substance development and manufacturing. They operate six manufacturing plants with two R&D centers, accredited by USFDA, EU GMP, EDQM, and KFDA. They provide services from process R&D through stability studies, scale-up, process validation, and commercial manufacturing, including high-potent/cytotoxic molecules and flow chemistry.

Basic Pharma

Netherlands

Basic Pharma is a full-service CDMO based in the Netherlands specializing in regulated pharmaceutical product development, manufacturing, and commercialization. They offer GMP-compliant manufacturing of medicinal products and formulations, active pharmaceutical ingredients, and analytical testing from lab scale to early clinical phase and beyond. Their state-of-the-art facility includes GMP-compliant clean rooms.

Evonik Industries AG

Canada

Evonik Industries AG is a global specialty chemicals company that operates as a leading CDMO for complex parenteral drug products, focusing on polymeric and lipid-based delivery systems including liposomes, nanoparticles, microparticles, implants, and LNP formulations. The company's Health Care division provides end-to-end CDMO services for small molecules, peptides, nucleic acids (mRNA, siRNA), and HPAPIs, with FDA-inspected facilities in the US and Canada and 34 FDA inspections with zero OAI outcomes.

Indian pharmaceutical CDMO specializing in pre-finished formulation intermediates (PFI) and finished dosage forms (FDF). Manufactures oral solids, oral liquids, injectables, ophthalmics, topicals, and inhalation products. Strong focus on pellet technology and nanotechnology-based drug delivery systems. CRAMS (Contract Research and Manufacturing Services) provider.

Aggrega Pharma, LLC

France

Aggrega Pharma LLC is a U.S.-based pharmaceutical company created in 2019 by four European-based pharmaceutical companies (Bluepharma, Rafarm, Substipharm, Welding) focused on developing, manufacturing, and marketing generic drug products. The company leverages its shareholders' development and commercial manufacturing facilities, including FDA-inspected sites in Portugal and Greece, with capabilities in oral solids, sterile injectables, and complex ophthalmics.

PharmaBlock Group

China

PharmaBlock Group is the parent entity of PharmaBlock (Stock code: 300725.SZSE), a leading CRDMO with 2,300 employees and 700+ global partners across 7 sites. The group provides building blocks, chemistry research, drug substance CDMO, and drug product CDMO services. It holds an EcoVadis Silver Medal for sustainability. Note: this is the same company as PharmaBlock (duplicate entry).

Astrea Pharma

France

Astrea Pharma is a CDMO founded with the purpose of building a customer-focused manufacturing network covering development to commercial supply. They acquired the Fontaine-les-Dijon solid dose manufacturing site from Recipharm and offer oral solid dose and aseptic manufacturing capabilities from development through commercial supply, with a focus on efficiency and value in the pharma supply chain.

Ofichem Group

Netherlands

Ofichem Group is a family-owned European CDMO and pharmaceutical supplier founded in 1975, headquartered in Ter Apel, Netherlands. The company provides end-to-end services from drug substance (API) development through finished drug product manufacturing, including sourcing and distribution. Ofichem has recently expanded through acquisitions of Meribel Pharma Solutions' Uppsala site (early-phase development, ADCs, oligonucleotides, PROTACs) and Avivia (formulation development).

Lannett CDMO

United States

Lannett CDMO is the contract development and manufacturing arm of Lannett Company, a generic pharmaceuticals company. Specializes in oral solid dose (OSD) and liquid formulations, including high-potency compounds and DEA-controlled substances. Operates a 425,000 sq ft cGMP-certified manufacturing facility in Seymour, Indiana with dedicated suites for potent drugs. Capabilities include technology transfers, modified release technology, complex formulations, and reformulation. Has over 100 product families currently in distribution. Acquired by Aurobindo Pharma USA Inc. for $250 million in July 2025. Revenue of $306 million in FY 2025.

Lavipharm

Greece

Lavipharm is a dynamic, international healthcare company listed on the Athens Stock Exchange since 1995, based in Greece. Their manufacturing plant is one of the few pharmaceutical manufacturing sites in Europe with fully integrated production lines, including dedicated lines for transdermal drug delivery systems (TDDS). The production facility covers 8,000 m2 and produces tablets, capsules, transdermal systems, oral liquids, creams, and ointments under strict GMP conditions. Lavipharm collaborates with FAMAR for contract manufacturing and has launched the first locally produced medical cannabis prescription product in Greece. They also partner with other companies for manufacturing services.

Adragos Pharma

Germany

Adragos Pharma is a globally operating CDMO headquartered in Munich, Germany, specializing in small molecule finished dosage forms. They operate six manufacturing sites across Europe and Japan: Athens (Greece, HPAPI capabilities), Halden (Norway, BFS sterile production), Jura (Switzerland, small-batch clinical/commercial), Kawagoe (Japan, ampoules and tablets), Livron (France, sterile liquids and suppositories), and Leipzig (Germany, semi-solid and non-sterile liquids).

CD Formulation

United States

CD Formulation provides formulation development, analytical services, drug packaging, and pharmaceutical excipient solutions for pharmaceutical and biotechnology companies. The company offers contract manufacturing and contract research services including liposome cGMP manufacturing, accelerated stability studies, and a wide range of formulation types including oral solid, injectable, and topical formulations. They also supply pharmaceutical excipients and active pharmaceutical ingredients.

Asymchem

China

Asymchem is a leading CDMO with 25+ years of experience, 9,700+ employees, and eight R&D and manufacturing sites. They specialize in complex chemistry for small molecule APIs, including peptide synthesis, and provide comprehensive CMC services from R&D through commercial production. They have 65+ successful regulatory inspections (FDA, NMPA, TGA, MFDS) and 1,100+ active clients with 600+ clinical and 40+ commercial projects.

Akriti Pharmaceuticals Pvt. Ltd.

India

Akriti Pharmaceuticals Pvt. Ltd. is an Indian pharmaceutical manufacturer with EU GMP and TGA approved manufacturing facilities. The company delivers affordable quality medicines across the world with efficient manufacturing services backed by a qualified technical team, operating as a contract manufacturer for global healthcare partners.

Pharmazeutische Fabrik Montavit GmbH

Austria

Pharmazeutische Fabrik Montavit GmbH is an Austrian family-owned pharmaceutical company founded in 1945 in Absam, Tyrol. The company researches, develops, and manufactures pharmaceutical products and medical devices, exporting to over 80 countries. Montavit offers contract manufacturing (Lohnherstellung/Auftragsfertigung) services to other pharmaceutical companies. Dosage forms include tablets, film-coated tablets, dragees, liquids, creams/gels, granulates, suppositories, sterile pre-filled syringes, laminate tubes, sterile blisters, and powders. The company's own product portfolio covers urology, gynecology, allergy, sleep, travel health, and herbal medicines, with the wound care product Acerbine being well-known.

Serán BioScience

United States

Seran BioScience is a US-based CDMO headquartered in Bend, Oregon, recognized as a world leader in drug delivery and formulation development. The company provides comprehensive drug development and clinical/commercial manufacturing services, specializing in spray drying and particle engineering, preformulation, dosage form development, and cGMP manufacturing. Seran recently secured $200M+ from Bain Capital to build a new 100,000 sqft commercial manufacturing facility for non-sterile oral solid dose pharmaceuticals.

Tiofarma

Netherlands

Tiofarma is a Dutch CDMO specializing in complex semi-solid formulations (creams and ointments) and emergency nasal sprays, offering services from pre-formulation through commercial supply. The company operates an EU-GMP and FDA-licensed manufacturing facility in Oud-Beijerland, Netherlands, with in-house R&D and analytical laboratories.

Huazhong Pharmaceutical Co., Ltd. (HPC) is a Chinese pharmaceutical company established in 1995, manufacturing APIs, intermediates, and finished dosage forms including tablets. The company has GMP manufacturing sites with capabilities in both biological transformations and chemical synthesis, producing products such as albendazole, isoniazid, paracetamol, and nifedipine tablets.

ACIC Pharmaceuticals Inc

Canada

ACIC Pharmaceuticals Inc is a CDMO headquartered in Coral Springs, Florida, providing integrated pharmaceutical solutions from molecule to market. They offer API manufacturing, CDMO services for complex injectables including long-acting and cytotoxic injectables, regulatory support, and pharmaceutical equipment solutions. They have 249 FDA-approved products across a wide range of dosage forms.

Eromol UK Ltd (Eramol)

United Kingdom

Eramol (formerly Eromol UK Ltd) is a UK-based CDMO specializing in bespoke clinical trial manufacturing services, founded by two Qualified Persons. The company provides end-to-end services including formulation development, primary manufacturing, clinical packaging, QP release, and global distribution from MHRA and HPRA-approved facilities, with a new sterile injectable site opening in early 2026.

Hebei Veyong Pharmaceutical Co.,Ltd.

China

Hebei Veyong Pharmaceutical Co., Ltd. is a large GMP-certified Chinese veterinary pharmaceutical enterprise specializing in the R&D, production, and sales of veterinary APIs and preparations. Key products include Ivermectin, Eprinomectin, Tiamulin Fumarate, and Oxytetracycline, with production bases in Shijiazhuang and Ordos.

Prahem Laboratories LLP

India

Prahem Laboratories LLP is an Indian pharmaceutical company and sister company of Sneha Medicare Pvt Ltd (established 1985). Based in Mumbai, they operate as a CMO/CDMO with capabilities in development, production, and marketing of specialty medicines, generic medicines, OTC products, and new therapeutic development. Listed on CPHI Online as CMO/CDMO with distributor/import-export and generics/biosimilars manufacturing capabilities. Their business verticals include APIs, finished dosage forms (including oncology and contrast media), and export to LATAM, CIS, and Southeast Asian markets.

Quality Chemical Laboratories (QCL)

United States

Quality Chemical Laboratories (QCL) is a US-based CDMO located in Wilmington, North Carolina, specializing in comprehensive analytical testing, formulation development, and GMP clinical manufacturing. The company offers API synthesis, method development, taste masking, enteric coating, tablet film coating, and controlled/immediate release formulation development. QCL is FDA-registered for analysis, API manufacture, drug product manufacturing, and packaging.

Cooper Pharma

Morocco

Cooper Pharma is a Moroccan pharmaceutical company with over 90 years of experience, manufacturing and marketing more than 100 drugs under license from 20+ international partners. The company operates the Tit Mellil manufacturing plant (20,000 m2, 500 employees, 45+ million units annually) for solid, liquid, and paste products, the MC Pharma effervescent tablet facility, and Gynebio Pharma, the first site in Africa dedicated to contraceptive hormone manufacturing. Cooper Pharma also acquired a Sanofi manufacturing site in Saudi Arabia and offers CMO services.

Micro-Sphere SA

Switzerland

Micro-Sphere SA is a Swiss pharmaceutical CDMO based in Ticino, Switzerland, specializing in spray drying, capsule filling, and a wide range of R&D services. The company has a 100% regulatory track record, has served over 200 clients from all continents, and worked with over 500 drug substances and drug products. Micro-Sphere operates ISO 8 clean rooms and is FDA-registered for manufacturing. The company has a partnership with Sferalp and provides spray drying of both aqueous and organic solutions.

Cambrex

Canada

Halo Pharmaceuticals, acquired by Cambrex in 2018 for $425 million and later sold to SK Capital Partners in 2023, is a drug product CDMO specializing in oral solids, liquids, creams, sterile and non-sterile ointments, complex formulations, pediatric indications, and controlled substances. The company operates 430,000 square feet of GMP-compliant manufacturing space across Whippany, New Jersey and Montreal, Quebec, serving over 85 clients.

Guobang Pharmaceutical Group is a global pharmaceutical manufacturing company based in Zhejiang, China, and is among China's top 100 pharmaceutical enterprises. The company specializes in APIs, key pharmaceutical intermediates, and formulations for both human and veterinary health, with products sold to over 115 countries and regions. Founded in 1996, the company employs over 4,000 people across 2,500+ acres of operational land.

Iasis Pharma S.A.

Greece

Iasis Pharma S.A. is a steadily growing Greek pharmaceutical company founded in Athens, engaged in the manufacture and marketing of a wide range of pharmaceutical products across multiple therapeutic areas. The company operates production facilities and offers products including oral solids, injectables, and topicals.

GENSENTA

Turkey

Gensenta (formerly Mustafa Nevzat Ilac, acquired by Amgen in 2012 and sold to Eczacibasi in 2020) is a vertically integrated Turkish pharmaceutical company with two manufacturing facilities in Yenibosna and Sekerpinar, Turkey. The company manufactures both drug products and raw materials (APIs), and has been recognized in the sterile injectable CDMO market. Gensenta is listed as part of the Eczacibasi group and produces pharmaceuticals including caspofungin.